ArticleRheumatology (Oxford, England)2021
High risk of coronary artery aneurysm in Kawasaki disease.
Article in Rheumatology (Oxford, England), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 31 citations in OpenAlex.
- Clinical characteristics and vascular involvement of Takayasu arteritis versus Kawasaki disease in infants and young children.Pediatric rheumatology online journal · 2026Article
- Myocardial Infarction in a 19-year-old with a History of Kawasaki Disease: A Case Report.Clinical practice and cases in emergency medicine · 2026Article
- Nomogram for Predicting Regression of Persistent Coronary Artery Aneurysms in Kawasaki Disease: A Three-year Follow-up Cohort Study in Southwest China.Journal of inflammation research · 2026Article
- Giant coronary aneurysms in children with Kawasaki disease and major cardiac complications and dynamic follow-up.World journal of clinical pediatrics · 2025Article
- Development and validation of an early predictive model for coronary artery lesions in incomplete Kawasaki disease.Translational pediatrics · 2025Article
- Spectrum of Coronary Artery Involvement With Multisystem Inflammatory Syndrome in Children Versus Kawasaki Disease.Journal of the American Heart Association · 2025Article
- Establishment and validation of a predictive model for coronary artery lesions in children with KDSS.Italian journal of pediatrics · 2025Article
- The Comparative Effectiveness of Intravenous Immunoglobulin and Corticosteroids in Kawasaki Disease: A Nationwide Claim Data Analysis.Journal of clinical medicine · 2025Article
- A machine learning algorithm to predict treatment effectiveness for Kawasaki disease in China: a retrospective model development and validation study.Frontiers in immunology · 2025Article
- Risk factors and scores for prediction of coronary artery aneurysms in Kawasaki disease: a European monocentric study.BMC pediatrics · 2024Article
- Predictive factors of medium-giant coronary artery aneurysms in Kawasaki disease.Pediatric research · 2024Article
- Article
- Retrospective analysis of children diagnosed with Kawasaki disease.Turkish journal of medical sciences · 2023Article
- Giant Coronary Aneurysms with Multiple Large Resistant Thromboses in an 8-Month-Old Boy with IVIg-Resistant Kawasaki Disease: A Case Report.The journal of Tehran Heart Center · 2023Article
- Article
- Bibliometric and visual analysis of Kawasaki disease in children from 2012 to 2022.Frontiers in pediatrics · 2023Article
- Complete and incomplete Kawasaki disease: Clinical differences and coronary artery outcome from a national prospective surveillance study in Switzerland.Frontiers in pediatrics · 2023Article
- Is Coronary Artery Ectasia a Progressive Disease? A Self-Controlled Retrospective Cohort Study.Frontiers in cardiovascular medicine · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 1 institution in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveKawasaki disease (KD) is a vasculitis of unknown aetiology with a high risk of coronary aneurysms if untreated. Timely treatment with intravenous immunoglobulin decreases the risk for coronary artery aneurysms (CAA). In this study, we set out to elucidate the factors associated with the risk of developing CAA.
methodsRecords of all KD-diagnosed children in Skåne between 2004 and 2014 were collected and clinical and demographic data were compiled. KD is defined according to the revised American Heart Association diagnostic criteria and classified as either complete KD (cKD) or incomplete KD (iKD).
resultsKD was diagnosed in 77 children and CAA was found in 31% (n = 24). Children with CAA were younger compared with children without (median; 20 vs 34 months) and intravenous immunoglobulin treatment within 10 days was less likely to be received (75% vs 91%). In children presenting with iKD, 47% developed CAA compared with 21% in cKD patients. Using multivariate analysis, an association between the risk of CAA with low age in children with iKD was observed.
conclusionThe risk of CAA development is disturbingly high in young children with iKD. This highlights the importance of rapid intense treatment and vigilance in infants, who are the most difficult to diagnose, in order to reduce the frequency of CAA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.